SOFENTIL

This brand name is authorized in Cyprus, Malta, Romania.

Active ingredients

The drug SOFENTIL contains one active pharmaceutical ingredient (API):

1
UNII S9ZFX8403R - SUFENTANIL CITRATE
 

Sufentanil is a synthetic, potent opioid with highly selective binding to μ-opioid receptors. Sufentanil acts as a full agonist in μ-opioid receptors. Sufentanil does not induce histamine release.

 
Read more about Sufentanil

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 SOFENTIL Solution for injection / infusion MPI, EU: SmPC Web Search

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
N01AH03 Sufentanil N Nervous system → N01 Anesthetics → N01A Anesthetics, general → N01AH Opioid anesthetics
Discover more medicines within N01AH03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
MT Medicines Authority MA032/12101, MA032/12102
RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale W65847001, W65847002, W65848001, W65848002

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.